Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
Yang Y, He Y, Fan Z, Chen X, Liu Y, Zhang C, Jiang H, Wang X, Wang X, Xie F, Wang S, Luo B, Kang H, Wang T, Jiang Z, Yuan P, Xu B, Xu L, Liu Y, Li J, Xie Y, Wang T, Ouyang T.
Yang Y, et al. Among authors: wang x, wang t, wang s.
NPJ Breast Cancer. 2023 Jun 21;9(1):54. doi: 10.1038/s41523-023-00553-y.
NPJ Breast Cancer. 2023.
PMID: 37344451
Free PMC article.